Clinical Trial Update: The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial is investigating the effects of SGLT2 inhibition on adipose inflammation and endothelial function in individuals with obesity a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome
• Obesity

Drugs mentioned

• SGLT2 inhibitor (class) (SGLT2 inhibitor)

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Obesity, Metabolic Syndrome | Phase 1, Phase 2 | Status: RECRUITING